This Week In Securities Litigation (Week of August 28, 2023)
Summer is heading for its traditional close at Labor Day as many have either returned to school or are finalizing their plans. The Commission…
Stay updated with breaking news from Daniel Vt Catenacci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Summer is heading for its traditional close at Labor Day as many have either returned to school or are finalizing their plans. The Commission…
A former University of Chicago professor who pled guilty to insider trading with information about a positive cancer drug trial he was involved in won't serve prison time after an Illinois federal judge sentenced him Wednesday to time served and a year of supervised release.
Eli Lilly Accused of Defrauding Government in $60 Million Qui Tam Suit - In a qui tam suit alleging that Eli Lilly and Co. (“Eli Lilly”) violated the False Claims Act, a...
A physician and professor at the University of Chicago entered a plea of not guilty Tuesday to charges that he traded on inside information from Five Prime Therapeutics Inc. ahead of the publication of positive results of a drug trial for its leading cancer drug bemarituzumab.
Dr Daniel Catenacci, the lead investigator in a clinical trial for the drug bemarituzumab, has been charged with violating the antifraud provisions of the federal securities laws.